Peripheral Blood Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationStem CellsTransplantation, HomologousTransplantation, AutologousBone MarrowHematopoietic Stem CellsHematopoietic Stem Cell MobilizationBone Marrow CellsGraft vs Host DiseaseGraft SurvivalStem Cell TransplantationTransplantation ConditioningGranulocyte Colony-Stimulating FactorCord Blood Stem Cell TransplantationTissue DonorsLeukapheresisHematologic NeoplasmsKidney TransplantationAntigens, CD34Immunosuppressive AgentsWhole-Body IrradiationBlood Component RemovalEmbryonic Stem CellsTreatment OutcomeLeukemiaHistocompatibility TestingAdult Stem CellsCombined Modality TherapyCyclophosphamideGraft RejectionCytomegalovirus InfectionsMelphalanTransplantsAnemia, AplasticHematopoiesisBusulfanHistocompatibilityRecurrenceTime FactorsCell DifferentiationTransplantation ChimeraRetrospective StudiesMultiple MyelomaPluripotent Stem CellsCyclosporineBlood CellsImmunosuppressionAntineoplastic Combined Chemotherapy ProtocolsStem Cell NicheBone Marrow PurgingLymphoma, Non-HodgkinColony-Forming Units AssayLeukemia, Myeloid, AcuteOpportunistic InfectionsImmunocompromised HostTransplantationBone Marrow DiseasesSurvival AnalysisStem Cell FactorNeural Stem CellsFetal BloodTransplantation, IsogeneicHeart TransplantationBlood Cell CountInduced Pluripotent Stem CellsRemission InductionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMesenchymal Stem Cell TransplantationSurvival RateInfectionMyeloablative AgonistsCell LineageMultipotent Stem CellsHematologic DiseasesDisease-Free SurvivalCells, CulturedPrecursor Cell Lymphoblastic Leukemia-LymphomaCell SeparationFlow CytometryMice, Inbred C57BLHLA AntigensAcute DiseaseThiotepaCytomegalovirusEtoposideFollow-Up StudiesLung TransplantationFatal OutcomeLymphocyte DepletionAntilymphocyte SerumAntineoplastic Agents, AlkylatingTransplantation ImmunologyMyelodysplastic SyndromesMesenchymal Stromal CellsTacrolimusHodgkin DiseaseGanciclovirBlood Group Incompatibility